8-K
filed August 1, 2022, 7:59 PM ET
ticker CADL
CIK 0001841387
leadership
confidence high
sentiment neutral
materiality 0.45
Candel Therapeutics appoints 3 new directors; 3 resign effective Aug 8, 2022
Candel Therapeutics, Inc.
- Renee Gaeta, Gary Nabel, and Joseph Papa join the board, replacing Alan Smith, Shaan Gandhi, and Udi Meirav.
- Gaeta is CFO of Eko Devices; Nabel is CEO of ModeX Therapeutics; Papa is CEO of Bausch + Lomb.
- Resignations were not due to any disagreement with the company on operations, policies, or practices.
- New directors each receive option to purchase 28,480 shares vesting over 3 years and standard cash compensation.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Dr. Gary Nabel was appointed as Director at Candel Therapeutics, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
The Board unanimously appointed Renee Gaeta, Dr. Gary Nabel and Joseph Papa, effective August 8, 2022, to fill the newly created vacancies on the Board resulting from the resignations of Dr. Gandhi, Dr. Meirav and Dr. Smith.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Renee Gaeta was appointed as Director at Candel Therapeutics, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
The Board unanimously appointed Renee Gaeta, Dr. Gary Nabel and Joseph Papa, effective August 8, 2022, to fill the newly created vacancies on the Board resulting from the resignations of Dr. Gandhi, Dr. Meirav and Dr. Smith.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Joseph Papa was appointed as Director at Candel Therapeutics, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
The Board unanimously appointed Renee Gaeta, Dr. Gary Nabel and Joseph Papa, effective August 8, 2022, to fill the newly created vacancies on the Board resulting from the resignations of Dr. Gandhi, Dr. Meirav and Dr. Smith.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Alan E. Smith resigned as Director at Candel Therapeutics, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On July 26, 2022, Shaan Gandhi, Udi Meirav, and Alan E. Smith resigned as members of the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) effective August 8, 2022.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Shaan Gandhi resigned as Director at Candel Therapeutics, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On July 26, 2022, Shaan Gandhi, Udi Meirav, and Alan E. Smith resigned as members of the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) effective August 8, 2022.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Udi Meirav resigned as Director at Candel Therapeutics, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On July 26, 2022, Shaan Gandhi, Udi Meirav, and Alan E. Smith resigned as members of the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) effective August 8, 2022.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.